1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. DNA2.0 Acquires MIGS

M&A Deal Summary

DNA2.0 Acquires MIGS

On April 26, 2016, DNA2.0 acquired life science company MIGS

Acquisition Highlights
  • This is DNA2.0’s 1st transaction in the Life Science sector.
  • This is DNA2.0’s 1st transaction in the United Kingdom.
  • This is DNA2.0’s 1st transaction in New Hampshire.

M&A Deal Summary
Date 2016-04-26
Target MIGS
Sector Life Science
Buyer(s) DNA2.0
Deal Type Add-on Acquisition

Target

MIGS

Lebanon, New Hampshire, United Kingdom
MIGS LLC is an integrated contract research organization specializing in humanization and the production of antibody and antibody-like molecules that support preclinical studies with microgram to gram quantities of protein.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DNA2.0

Menlo Park, California, United States
Category Company
Founded 2003
Sector Life Science
DESCRIPTION

DNA2.0, Inc. is a bioengineering solutions provider, offering an integrated pipeline of solutions including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering. DNA2.0 explores novel applications for synthetic genes and the synergy between efficient gene design and protein optimization technologies.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Hampshire M&A 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal